Top Story

Milner Therapeutics Institute adds US pharma giant Pfizer to Consortium

Consortium acts as a 'matchmaking' service between pharma and academia.

Read more

Agreement creates a group with revenues of more than €300 million....

Read more

Decision based on data from two Phase 3 studies, LixiLan-O and LixiLan-L....

Read more

Decision comes despite daratumumab meeting the SMC's end-of-life....

Read more

New models of working are supporting UK economy....

Read more

Abbott will occupy high position across cardiovascular-device markets....

Read more

Tobacco use is single biggest preventable cause of death globally....

Read more

ABPI advocated for the new funding mechanism....

Read more

F901318 will enter Phase II clinical development in mid-2017....

Read more

Companies sign research collaboration, option, and asset deal....

Read more

Researchers at UM SOM tested the virus using fission yeast....

Read more